Neurofibromatosis Incorporated Northeast
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 544,587 | 550,008 | −5,421 | 10.1 | 18% |
| 2012 | 559,896 | 580,437 | −20,541 | 9.1 | 17% |
| 2013 | 541,707 | 604,509 | −62,802 | 7.6 | 17% |
| 2014 | 780,259 | 696,031 | 84,228 | 8.0 | 15% |
| 2015 | 743,683 | 719,406 | 24,277 | 8.1 | 14% |
| 2016 | 789,902 | 691,395 | 98,507 | 10.1 | 14% |
| 2017 | 780,879 | 734,348 | 46,531 | 10.5 | 40% |
| 2018 | 679,566 | 688,256 | −8,690 | 10.6 | 48% |
| 2019 | 687,701 | 676,597 | 11,104 | 11.8 | 48% |
| 2020 | 439,880 | 484,116 | −44,236 | 16.3 | 42% |
| 2021 | 737,666 | 451,337 | 286,329 | 25.4 | 32% |
| 2022 | 616,977 | 651,825 | −34,848 | 15.1 | 35% |
| 2023 | 558,976 | 642,447 | −83,471 | 14.2 | 37% |
In its most recent public year (2023), this organization spent $83,471 more than it brought in. Its reserves stood at about 14.2 months of spending, up from 10.1 in 2011. Staff pay was 37% of spending. $130,458 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Neurofibromatosis Incorporated Northeast's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works